<DOC>
	<DOCNO>NCT01409486</DOCNO>
	<brief_summary>The aim study : develop comprehensive biochemical assay detection Pompe disease ( glycogen storage disease type II ) , implement Newborn screen program among Israeli population .</brief_summary>
	<brief_title>Screening Early Detection Prevention Pompe Disease Israel Using Tandem Mass Spectrometry</brief_title>
	<detailed_description />
	<mesh_term>Glycogen Storage Disease Type II</mesh_term>
	<criteria>New born baby bear study period Premature baby</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>7 Days</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Pompe disease</keyword>
	<keyword>Alpha glucosidase</keyword>
	<keyword>Newborn screening</keyword>
	<keyword>Tandem Mass Spectrometry ( LC-MS-MS )</keyword>
	<keyword>The study aim :</keyword>
	<keyword>To establish control mean value alpha glucosidase activity Dry blood spot Newborn baby Israel .</keyword>
	<keyword>To include alpha glucosidase assay newborn screen program Israel</keyword>
</DOC>